This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Marinomed Biotech Ag. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Cornelia Kaintz: Innovator in Pharmaceutical Solubility Solutions
Introduction
Cornelia Kaintz is a notable inventor based in Vienna, Austria. She has made significant contributions to the field of pharmaceuticals, particularly in enhancing the solubility of water-insoluble drugs. Her innovative approach has the potential to improve drug delivery and efficacy.
Latest Patents
Cornelia Kaintz holds a patent for a method aimed at improving the aqueous solubility of water-insoluble or slightly water-soluble drugs. The patent describes a process that involves adding a saponin component, such as escin or glycyrrhizin, to an aqueous solvent. This method triggers the formation of micelles, allowing hydrophobic organic compounds to be solubilized and dissolved in the aqueous solvent. The resulting aqueous composition has an increased concentration of the organic compound, which can be beneficial for pharmaceutical and cosmetic applications.
Career Highlights
Cornelia Kaintz is associated with Marinomed Biotech AG, a company known for its innovative solutions in the biotechnology sector. Her work focuses on developing methods that enhance drug solubility, which is crucial for effective pharmaceutical formulations.
Collaborations
She collaborates with esteemed colleagues, including Andreas Grassauer and Angelika Bodenteich, who contribute to her research and development efforts. Their combined expertise fosters a productive environment for innovation in drug solubility.
Conclusion
Cornelia Kaintz's contributions to pharmaceutical science, particularly in improving drug solubility, highlight her role as an influential inventor. Her patented methods have the potential to significantly impact the effectiveness of various pharmaceutical and cosmetic products.